Latest Insider Transactions at Encompass Health Corp (EHC)
This section provides a real-time view of insider transactions for Encompass Health Corp (EHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Encompass Health Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Encompass Health Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 18
2022
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
40
+0.39%
|
-
|
|
Apr 18
2022
|
L Edward Shaw Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
298
+0.3%
|
-
|
|
Apr 18
2022
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
20
+0.38%
|
-
|
|
Mar 30
2022
|
Kevin J. O'Connor Director |
BUY
Grant, award, or other acquisition
|
Direct |
209
+50.0%
|
-
|
|
Feb 25
2022
|
Elissa Joy Charbonneau Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,406
+10.41%
|
-
|
|
Feb 25
2022
|
Douglas E Coltharp EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,870
+15.0%
|
-
|
|
Feb 25
2022
|
John Patrick Darby EVP, Gen Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
8,426
+8.22%
|
-
|
|
Feb 25
2022
|
Edmund Fay Sr. Vice Pres. and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
4,309
+2.3%
|
-
|
|
Feb 25
2022
|
Barbara Ann Jacobsmeyer President & CEO, HHH |
BUY
Grant, award, or other acquisition
|
Direct |
15,772
+12.42%
|
-
|
|
Feb 25
2022
|
Andrew L Price Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,582
+3.39%
|
-
|
|
Feb 25
2022
|
Mark J Tarr President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
47,988
+5.41%
|
-
|
|
Feb 24
2022
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
296
-1.51%
|
$19,240
$65.52 P/Share
|
|
Feb 24
2022
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
698
-1.85%
|
$45,370
$65.52 P/Share
|
|
Feb 24
2022
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
330
-0.81%
|
$21,450
$65.52 P/Share
|
|
Feb 24
2022
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
247
-0.28%
|
$16,055
$65.52 P/Share
|
|
Feb 24
2022
|
Barbara Ann Jacobsmeyer President & CEO, HHH |
SELL
Payment of exercise price or tax liability
|
Direct |
584
-1.32%
|
$37,960
$65.52 P/Share
|
|
Feb 24
2022
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
265
-0.43%
|
$17,225
$65.52 P/Share
|
|
Feb 24
2022
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,873
-0.49%
|
$121,745
$65.52 P/Share
|
|
Feb 22
2022
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,270
-3.25%
|
$82,550
$65.91 P/Share
|
|
Feb 22
2022
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
604
-3.0%
|
$39,260
$65.91 P/Share
|
|
Feb 22
2022
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
673
-1.63%
|
$43,745
$65.91 P/Share
|
|
Feb 22
2022
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
507
-0.57%
|
$32,955
$65.91 P/Share
|
|
Feb 22
2022
|
Barbara Ann Jacobsmeyer President & CEO, HHH |
SELL
Payment of exercise price or tax liability
|
Direct |
1,048
-2.31%
|
$68,120
$65.91 P/Share
|
|
Feb 22
2022
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
525
-0.84%
|
$34,125
$65.91 P/Share
|
|
Feb 22
2022
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,782
-0.98%
|
$245,830
$65.91 P/Share
|
|
Feb 08
2022
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,509
-29.72%
|
$1,023,558
$62.15 P/Share
|
|
Feb 08
2022
|
Douglas E Coltharp EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,132
+31.99%
|
$548,772
$21.02 P/Share
|
|
Jan 21
2022
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
399
+19.84%
|
$24,738
$62.51 P/Share
|
|
Jan 20
2022
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
498
+0.4%
|
$30,876
$62.59 P/Share
|
|
Jan 19
2022
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
231
+0.19%
|
$14,091
$61.21 P/Share
|
|
Jan 19
2022
|
John E Jr D D S Maupin Director |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.01%
|
$427
$61.26 P/Share
|
|
Jan 19
2022
|
L Edward Shaw Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
67
+0.07%
|
$4,087
$61.17 P/Share
|
|
Jan 18
2022
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.46%
|
-
|
|
Jan 18
2022
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
328
+0.26%
|
-
|
|
Jan 18
2022
|
Donald L Correll Director |
BUY
Grant, award, or other acquisition
|
Direct |
343
+0.44%
|
-
|
|
Jan 18
2022
|
Yvonne M Curl Director |
BUY
Grant, award, or other acquisition
|
Direct |
343
+0.44%
|
-
|
|
Jan 18
2022
|
Charles M Elson Director |
BUY
Grant, award, or other acquisition
|
Direct |
343
+0.41%
|
-
|
|
Jan 18
2022
|
Joan E Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
139
+0.44%
|
-
|
|
Jan 18
2022
|
Leo I Higdon Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
343
+6.66%
|
-
|
|
Jan 18
2022
|
Leslye G Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
139
+0.44%
|
-
|
|
Jan 18
2022
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.46%
|
-
|
|
Jan 18
2022
|
John E Jr D D S Maupin Director |
BUY
Grant, award, or other acquisition
|
Direct |
343
+0.42%
|
-
|
|
Jan 18
2022
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.49%
|
-
|
|
Jan 18
2022
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
46
+0.45%
|
-
|
|
Jan 18
2022
|
L Edward Shaw Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
343
+0.35%
|
-
|
|
Jan 18
2022
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.43%
|
-
|
|
Jan 03
2022
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,206
-5.65%
|
$78,390
$65.26 P/Share
|
|
Jan 03
2022
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,226
-12.56%
|
$274,690
$65.26 P/Share
|
|
Jan 03
2022
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,537
-5.78%
|
$164,905
$65.26 P/Share
|
|
Jan 03
2022
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,025
-1.14%
|
$66,625
$65.26 P/Share
|